Haier BioMedical Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Public

  • Employees
  • 2,945

Employees

  • Stock Symbol
  • 688139

Stock Symbol

  • Investments
  • 15

  • Share Price
  • $4.47
  • (As of Friday Closing)

Haier BioMedical General Information

Description

Qingdao Haier Biomedical Co Ltd is engaged in designing, manufacturing, marketing, and sales of low-temperature storage equipment for biomedical samples. The company provides complete storage solutions for biological sample banks, blood safety, vaccine safety, medical supplies, and reagent safety.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • No. 280 Feng Yuan Road
  • High-tech Zone, Qingdao
  • Qingdao, Shandong 266109
  • China
+86 400
Primary Industry
Medical Supplies
Stock Exchange
SHG
Vertical(s)
Corporate Office
  • No. 280 Feng Yuan Road
  • High-tech Zone, Qingdao
  • Qingdao, Shandong 266109
  • China
+86 400

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Haier BioMedical Stock Performance

As of 20-Nov-2026, Haier BioMedical’s stock price is $4.47. Its current market cap is $1.41B with 316M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.47 $4.55 $3.59 - $5.59 $1.41B 316M 3.86M $0.13

Haier BioMedical Financials Summary

As of 30-Sep-2026, Haier BioMedical has a trailing 12-month revenue of $367M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 1,512,101 1,293,119 1,318,759 1,548,292
Revenue 367,266 323,817 318,284 322,394
EBITDA 38,084 49,899 66,649 71,497
Net Income 39,469 34,866 51,095 57,397
Total Assets 888,293 827,749 792,793 779,517
Total Debt 13,286 13,599 4,198 4,161
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Haier BioMedical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Haier BioMedical‘s full profile, request access.

Request a free trial

Haier BioMedical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Haier BioMedical Investments & Acquisitions (15)

Haier BioMedical’s most recent deal was a Merger/Acquisition with Metash. The deal was made on 23-May-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Metash 23-May-2024 Merger/Acquisition Other Devices and Supplies
Chaolian Technology (Electrical Equipment) 16-Jun-2023 Merger/Acquisition Electrical Equipment
Haier Biomedical (Medical Supplies) 03-Apr-2023 Merger/Acquisition Medical Supplies
Suzhou Kangsheng 02-Dec-2022 Merger/Acquisition Medical Supplies
Jinweixin 27-Oct-2022 Merger/Acquisition Other Healthcare Technology Systems
You’re viewing 5 of 15 investments and acquisitions. Get the full list »

Haier BioMedical ESG

Risk Overview

Risk Rating

Updated November, 30, 2024

17.91 | Low Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,999

Rank

Percentile

Pharmaceuticals

Industry

of 952

Rank

Percentile

Laboratory Equipment and Services

Subindustry

of 70

Rank

Percentile

To view Haier BioMedical’s complete esg history, request access »

Haier BioMedical Exits (1)

Haier BioMedical’s most recent exit was on 04-Jan-2016 from Labtech International. The exit was categorized as with 3 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Labtech International 04-Jan-2016 Completed
  • 3 buyers
To view Haier BioMedical’s complete exits history, request access »

Haier BioMedical Affiliates

Subsidiaries (6)

Name Industry Location Year Founded
Suzhou Kangsheng Suzhou, China 2020
Chaolian Technology (Electrical Equipment) Shanghai, China 2020
Haier Biomedical (Medical Supplies) Suzhou, China 2015
Metash Shanghai, China 2008
Chongqing Sandaweiye Chongqing, China 2001
You’re viewing 5 of 6 affiliates. Get the full list.  »

Haier BioMedical FAQs

  • When was Haier BioMedical founded?

    Haier BioMedical was founded in 1998.

  • Where is Haier BioMedical headquartered?

    Haier BioMedical is headquartered in Qingdao, China.

  • What is the size of Haier BioMedical?

    Haier BioMedical has 2,945 total employees.

  • What industry is Haier BioMedical in?

    Haier BioMedical’s primary industry is Medical Supplies.

  • Is Haier BioMedical a private or public company?

    Haier BioMedical is a Public company.

  • What is Haier BioMedical’s stock symbol?

    The ticker symbol for Haier BioMedical is 688139.

  • What is the current stock price of Haier BioMedical?

    As of 20-Nov-2026 the stock price of Haier BioMedical is $4.47.

  • What is the current market cap of Haier BioMedical?

    The current market capitalization of Haier BioMedical is $1.41B.

  • What is Haier BioMedical’s current revenue?

    The trailing twelve month revenue for Haier BioMedical is $367M.

  • What is Haier BioMedical’s annual earnings per share (EPS)?

    Haier BioMedical’s EPS for 12 months was $0.13.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process